---
document_datetime: 2023-09-21 18:53:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/rilonacept-regeneron-epar-all-authorised-presentations_en.pdf
document_name: rilonacept-regeneron-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8119522
conversion_datetime: 2025-12-14 13:45:59.430366
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## EU Number

EU/1/09/582/001

Invented name Rilonacept Regeneron

## Strength

## Pharmaceutical Form

Route of

Administration

Subcutaneous use

## Packaging

## Content

Medicinal product no longer authorised 80 mg/ml Powder and solvent for solution for injection Powder: vial (glass) Solvent: LDPE vial

<!-- image -->

## Package size

4 vials powder+ 4 vials solvent + 8 disposable 3 ml syringes + 8 disposable 27-gauge, Â½ inch needles